Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Detection of Hpdel in healthy individuals and cancer patients in Taiwan

Identifieur interne : 001882 ( Main/Exploration ); précédent : 001881; suivant : 001883

Detection of Hpdel in healthy individuals and cancer patients in Taiwan

Auteurs : Yu-Chieh Su ; Yi-Chun Chen ; Szu-Chin Li ; Ching-Chih Lee ; Ya-Ting Tung [République populaire de Chine]

Source :

RBID : ISTEX:D6ED6D4EE65102F1976898EADC1B595C6EB78B39

English descriptors

Abstract

Background: We investigated the genotypic distribution of Hpdel in healthy subjects and cancer patients in Taiwan. Methods: Blood samples were collected from 244 randomly selected healthy Taiwanese volunteers and 737 patients with various cancers. Samples were analyzed for the haptoglobin (Hp) gene, and the presence of the Hpdel allele was determined from genomic DNA by an Hpdel-specific polymerase chain reaction (PCR) method. The plasma concentration of Hp was also determined. Results: The frequency of the Hpdel allele was calculated to be 0.029, and was not different between the healthy subjects and patients with cancer. The prevalence of Hp deficiency caused by Hpdel homozygosity was estimated to be ∼0.85 in 1000. Fifty-seven subjects were reclassified from homozygous Hp1 or Hp2 to Hp1/Hpdel or Hp2/Hpdel genotypes. The Hpdel allele is not associated with prevalence, severity or stage of any cancer. Conclusions: Congenital Hp deficiency caused by Hpdel homozygosity is a condition present in Taiwan with a relatively high frequency. However, the Hpdel variant does not play a role in cancer. Clin Chem Lab Med 2009;47:745–9.

Url:
DOI: 10.1515/CCLM.2009.156


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Detection of Hpdel in healthy individuals and cancer patients in Taiwan</title>
<author>
<name sortKey="Su, Yu Chieh" sort="Su, Yu Chieh" uniqKey="Su Y" first="Yu-Chieh" last="Su">Yu-Chieh Su</name>
</author>
<author>
<name sortKey="Chen, Yi Chun" sort="Chen, Yi Chun" uniqKey="Chen Y" first="Yi-Chun" last="Chen">Yi-Chun Chen</name>
</author>
<author>
<name sortKey="Li, Szu Chin" sort="Li, Szu Chin" uniqKey="Li S" first="Szu-Chin" last="Li">Szu-Chin Li</name>
</author>
<author>
<name sortKey="Lee, Ching Chih" sort="Lee, Ching Chih" uniqKey="Lee C" first="Ching-Chih" last="Lee">Ching-Chih Lee</name>
</author>
<author>
<name sortKey="Tung, Ya Ting" sort="Tung, Ya Ting" uniqKey="Tung Y" first="Ya-Ting" last="Tung">Ya-Ting Tung</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D6ED6D4EE65102F1976898EADC1B595C6EB78B39</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1515/CCLM.2009.156</idno>
<idno type="url">https://api.istex.fr/ark:/67375/QT4-WLM2KFLQ-2/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002552</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002552</idno>
<idno type="wicri:Area/Istex/Curation">002552</idno>
<idno type="wicri:Area/Istex/Checkpoint">000807</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000807</idno>
<idno type="wicri:doubleKey">1434-6621:2009:Su Y:detection:of:hpdel</idno>
<idno type="wicri:Area/Main/Merge">001886</idno>
<idno type="wicri:Area/Main/Curation">001882</idno>
<idno type="wicri:Area/Main/Exploration">001882</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Detection of Hpdel in healthy individuals and cancer patients in Taiwan</title>
<author>
<name sortKey="Su, Yu Chieh" sort="Su, Yu Chieh" uniqKey="Su Y" first="Yu-Chieh" last="Su">Yu-Chieh Su</name>
</author>
<author>
<name sortKey="Chen, Yi Chun" sort="Chen, Yi Chun" uniqKey="Chen Y" first="Yi-Chun" last="Chen">Yi-Chun Chen</name>
</author>
<author>
<name sortKey="Li, Szu Chin" sort="Li, Szu Chin" uniqKey="Li S" first="Szu-Chin" last="Li">Szu-Chin Li</name>
</author>
<author>
<name sortKey="Lee, Ching Chih" sort="Lee, Ching Chih" uniqKey="Lee C" first="Ching-Chih" last="Lee">Ching-Chih Lee</name>
</author>
<author>
<name sortKey="Tung, Ya Ting" sort="Tung, Ya Ting" uniqKey="Tung Y" first="Ya-Ting" last="Tung">Ya-Ting Tung</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Division of Hematology-Oncology, Department of Internal Medicine, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="issue">Special Issue: Proteomics and Biomarkers</title>
<title level="j" type="abbrev">Clinical Chemistry and Laboratory Medicine</title>
<idno type="eISSN">1437-4331</idno>
<idno type="ISSN">1434-6621</idno>
<imprint>
<publisher>Walter de Gruyter</publisher>
<date>2009</date>
<date type="e-published">2009</date>
<biblScope unit="vol">47</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="745">745</biblScope>
<biblScope unit="page" to="749">749</biblScope>
<biblScope unit="ref-count">27</biblScope>
<biblScope unit="fig-count">0</biblScope>
<biblScope unit="table-count">4</biblScope>
</imprint>
<idno type="ISSN">1434-6621</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1434-6621</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Allele</term>
<term>Allele frequency</term>
<term>Anaphylactic transfusion reactions</term>
<term>Antihaptoglobin antibody</term>
<term>Blood products</term>
<term>Blood samples</term>
<term>Buddhist dalin</term>
<term>Cancer patients</term>
<term>Cancer stage</term>
<term>Carcinoma</term>
<term>Case reports</term>
<term>Cell carcinoma</term>
<term>Chem</term>
<term>Clin</term>
<term>Clin chem</term>
<term>Clin pathol</term>
<term>Clinical characteristics</term>
<term>Clinical stage</term>
<term>Colon rectal cancer</term>
<term>Congenital</term>
<term>Different cancer groups</term>
<term>General hospital</term>
<term>Genetic survey</term>
<term>Genotype</term>
<term>Haptoglobin</term>
<term>Haptoglobin deficiency</term>
<term>Haptoglobin types</term>
<term>Healthy controls</term>
<term>Healthy group</term>
<term>Healthy individuals</term>
<term>Healthy subjects</term>
<term>Healthy taiwanese volunteers</term>
<term>Hepatocelluar carcinoma</term>
<term>Hpdel</term>
<term>Hpdel allele</term>
<term>Hpdel frequency</term>
<term>Hpdel genotype distribution</term>
<term>Hpdel homozygosity</term>
<term>Hpdel variant</term>
<term>Internal medicine</term>
<term>Koda</term>
<term>Nasopharyngeal carcinoma</term>
<term>Other areas</term>
<term>Phenotype</term>
<term>Polymerase chain reaction</term>
<term>Polymorphism</term>
<term>Promoter region</term>
<term>Severe transfusion reactions</term>
<term>Significant difference</term>
<term>Soejima</term>
<term>Such reactions</term>
<term>Taiwanese population</term>
<term>Transfusion</term>
<term>Various cancers</term>
<term>Various types</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: We investigated the genotypic distribution of Hpdel in healthy subjects and cancer patients in Taiwan. Methods: Blood samples were collected from 244 randomly selected healthy Taiwanese volunteers and 737 patients with various cancers. Samples were analyzed for the haptoglobin (Hp) gene, and the presence of the Hpdel allele was determined from genomic DNA by an Hpdel-specific polymerase chain reaction (PCR) method. The plasma concentration of Hp was also determined. Results: The frequency of the Hpdel allele was calculated to be 0.029, and was not different between the healthy subjects and patients with cancer. The prevalence of Hp deficiency caused by Hpdel homozygosity was estimated to be ∼0.85 in 1000. Fifty-seven subjects were reclassified from homozygous Hp1 or Hp2 to Hp1/Hpdel or Hp2/Hpdel genotypes. The Hpdel allele is not associated with prevalence, severity or stage of any cancer. Conclusions: Congenital Hp deficiency caused by Hpdel homozygosity is a condition present in Taiwan with a relatively high frequency. However, the Hpdel variant does not play a role in cancer. Clin Chem Lab Med 2009;47:745–9.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chen, Yi Chun" sort="Chen, Yi Chun" uniqKey="Chen Y" first="Yi-Chun" last="Chen">Yi-Chun Chen</name>
<name sortKey="Lee, Ching Chih" sort="Lee, Ching Chih" uniqKey="Lee C" first="Ching-Chih" last="Lee">Ching-Chih Lee</name>
<name sortKey="Li, Szu Chin" sort="Li, Szu Chin" uniqKey="Li S" first="Szu-Chin" last="Li">Szu-Chin Li</name>
<name sortKey="Su, Yu Chieh" sort="Su, Yu Chieh" uniqKey="Su Y" first="Yu-Chieh" last="Su">Yu-Chieh Su</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Tung, Ya Ting" sort="Tung, Ya Ting" uniqKey="Tung Y" first="Ya-Ting" last="Tung">Ya-Ting Tung</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001882 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001882 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D6ED6D4EE65102F1976898EADC1B595C6EB78B39
   |texte=   Detection of Hpdel in healthy individuals and cancer patients in Taiwan
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021